KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilent Technologies (A) Research & Development (2016 - 2026)

Agilent Technologies (A) has disclosed Research & Development for 17 consecutive years, with $117.0 million as the latest value for Q1 2026.

  • Quarterly Research & Development rose 3.54% to $117.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $459.0 million through Jan 2026, down 1.08% year-over-year, with the annual reading at $455.0 million for FY2025, 5.01% down from the prior year.
  • Research & Development for Q1 2026 was $117.0 million at Agilent Technologies, down from $119.0 million in the prior quarter.
  • The five-year high for Research & Development was $128.0 million in Q1 2024, with the low at $111.0 million in Q4 2024.
  • Average Research & Development over 5 years is $117.6 million, with a median of $117.0 million recorded in 2022.
  • The sharpest move saw Research & Development increased 13.59% in 2022, then dropped 12.6% in 2025.
  • Over 5 years, Research & Development stood at $119.0 million in 2022, then decreased by 4.2% to $114.0 million in 2023, then dropped by 2.63% to $111.0 million in 2024, then rose by 7.21% to $119.0 million in 2025, then dropped by 1.68% to $117.0 million in 2026.
  • According to Business Quant data, Research & Development over the past three periods came in at $117.0 million, $119.0 million, and $111.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.